[Changes in the sale and use of flunitrazepam in Norway after 1999].

@article{Bramness2006ChangesIT,
  title={[Changes in the sale and use of flunitrazepam in Norway after 1999].},
  author={J\orgen Gustav Bramness and Svetlana Skurtveit and Kari Furu and Anders Engeland and Solveig Sakshaug and Marit R\onning},
  journal={Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke},
  year={2006},
  volume={126 5},
  pages={589-90}
}
BACKGROUND In Norway there has in later years been much discussion of misuse of flunitrazepam. From 1 January 2003 the drug was moved up one level in the schedule of controlled substances. On 1 August 2004 the manufacturer of the Rohypnol brand withdrew it from the Norwegian market. How did these two events influence the sales and use of drugs containing… CONTINUE READING